Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × selinexor × Plasma cell × Clear all

Status

Recruiting 10 Active not recruiting 10 Completed 9 Withdrawn 4 Unknown 3 Terminated 2 Not yet recruiting 1 No longer available 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

elotuzumab 4 Panobinostat 2 Lenalidomide 2 Dexamethasone 2 Bortezomib 2 selinexor 1 pomalidomide 1 plerixafor 1 fludarabine phosphate 1 carfilzomib 1 Whole-Body Irradiation 1 Tacrolimus 1 Prednisone 1 Mycophenolic Acid 1 Melphalan 1 Cytarabine 1 Crizotinib 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03850704 2019-02-22

Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma

Masonic Cancer Center, University of Minnesota

No longer available

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡